Wu Guosheng, Korsgren Olle, Sun Shibo, Van Rooijen Nico, Tibell Annika
Department of Transplantation Surgery, Huddinge Hospital, Karolinska Institutet, Stockholm, Sweden.
Xenotransplantation. 2003 May;10(3):214-22. doi: 10.1034/j.1399-3089.2003.01088.x.
The present study aimed to evaluate the effect of plasma exchange (PE) in combination with certain immunosuppressive agents on the survival of guinea-pig hearts in C6-deficient (C6-) rats. To deplete macrophages, we gave liposome-encapsulated dichloromethylene diphosphonate (Lip-Cl2MDP) intravenously (i.v.) in a dose of 10 mg/kg on day 2 before transplantation and every 5 days until rejection. Deoxyspergualin (DSG) was also given i.v. in a dose of 10 mg/kg/day from day -2 until rejection. Plasma exchange was performed 1 day before xenografting. All animals were splenectomized just before heart transplantation. Heart xenografts were evaluated twice daily and harvested at the time of rejection. The serum levels of anti-guinea-pig xenoreactive antibody (IgM, IgG) were measured using enzyme-linked immunosorbent assay (ELISA). Graft survival was 2.8 +/- 0.5 days in control rats, and 4.0 +/- 0.3 days with PE alone. A combination of PE with Lip-Cl2MDP or DSG did not improve the results (4.2 +/- 0.6 days vs. 4.8 +/- 0.6 days, respectively). While in rats treated with PE and the combination of Lip-Cl2MDP and DSG, graft survival was significantly prolonged (6.9 +/- 1.1 days, P < 0.01 vs. controls). In untreated control rats, xenoreactive antibody (IgM, IgG) levels decreased immediately after PE, but their levels rapidly returned to normal. In rats treated with DSG or DSG + Lip-Cl2MDP, the IgM levels remained low during the observation period. Immunohistochemistry showed that macrophage infiltration into the graft was suppressed in Lip-Cl2MDP-treated groups at the time of rejection. Our results demonstrate that sustained suppression of antibody levels can be achieved by PE in combination with DSG and xenograft survival is further prolonged in macrophage-depleted C6- rats. These findings suggest that strategies targeting antibody and macrophages may be useful in prolonging xenograft survival.
本研究旨在评估血浆置换(PE)联合某些免疫抑制剂对C6缺陷(C6-)大鼠体内豚鼠心脏存活的影响。为了清除巨噬细胞,我们在移植前第2天静脉注射(i.v.)剂量为10 mg/kg的脂质体包裹的二氯亚甲基二膦酸盐(Lip-Cl2MDP),并每5天注射一次,直至发生排斥反应。去氧精胍菌素(DSG)也从第-2天开始以10 mg/kg/天的剂量静脉注射,直至发生排斥反应。在异种移植前1天进行血浆置换。所有动物在心脏移植前均进行了脾切除术。每天对心脏异种移植物进行两次评估,并在排斥反应发生时进行采集。使用酶联免疫吸附测定(ELISA)测量抗豚鼠异种反应性抗体(IgM、IgG)的血清水平。对照大鼠的移植物存活时间为2.8±0.5天,单独使用PE时为4.0±0.3天。PE与Lip-Cl2MDP或DSG联合使用并没有改善结果(分别为4.2±0.6天和4.8±0.6天)。而在用PE以及Lip-Cl2MDP和DSG联合治疗的大鼠中,移植物存活时间显著延长(6.9±1.1天,与对照组相比P<0.01)。在未治疗的对照大鼠中,异种反应性抗体(IgM、IgG)水平在PE后立即下降,但其水平迅速恢复正常。在用DSG或DSG+Lip-Cl2MDP治疗的大鼠中,IgM水平在观察期内保持较低。免疫组织化学显示,在排斥反应时,Lip-Cl2MDP治疗组移植物中的巨噬细胞浸润受到抑制。我们的结果表明,PE联合DSG可以持续抑制抗体水平,并且在巨噬细胞耗竭的C6-大鼠中异种移植物存活时间进一步延长。这些发现表明,针对抗体和巨噬细胞的策略可能有助于延长异种移植物的存活时间。